Background:Hepatocellular carcinoma(HCC)is a highly lethal malignancy driven by both intrinsic oncogenic pathways and immune microenvironmental regulation.Emerging evidence suggests that DNASE1L3 may influence tumor b...Background:Hepatocellular carcinoma(HCC)is a highly lethal malignancy driven by both intrinsic oncogenic pathways and immune microenvironmental regulation.Emerging evidence suggests that DNASE1L3 may influence tumor biology and immune responses;however,its specific roles in HCC progression and macrophage-mediated regulation remain unclear.This study aimed to elucidate the biological functions of DNASE1L3 in HCC and to determine how it modulates tumor behavior and immune interactions.Methods:Bioinformatics analyses of the GSE41804 and Cancer Genome Atlas-Liver Hepatocellular Carcinoma(TCGA-LIHC)datasets were used to identify hub genes.Functional assays assessed the impact of DNASE1L3 on HCC cell proliferation,migration,invasion,and cell cycle progression.The effects of DNASE1L3 on macrophage polarization and the Wnt/β-catenin signaling pathway were examined using a co-culture system.An HCC organoid model was established to further validate its regulatory function.Results:Eight prognostic signature genes were identified,with deoxyribonuclease I-like 3(DNase I-like 3)selected as the hub gene.DNASE1L3 overexpression suppressed HCC cell growth,inhibited migration and invasion,induced G1 arrest,and modulated epithelial-mesenchymal transition(EMT)markers.DNASE1L3 knockdown promoted M2-like macrophage polarization.Mechanistically,DNASE1L3 interacted withβ-catenin to enhance its ubiquitination and degradation,thereby inhibiting Wnt/β-catenin signaling and reducing PD-L1 expression.DNASE1L3 overexpression similarly restricted organoid growth and suppressed pathway activity.Conclusion:DNASE1L3 acts as a negative regulator of HCC progression by targeting the Wnt/β-catenin pathway and reducing PD-L1 expression,thereby influencing both tumor cell behavior and macrophage-mediated immune responses.展开更多
BACKGROUND Hepatocellular carcinoma(HCC)has been a pervasive malignancy throughout the world with elevated mortality.Efficient therapeutic targets are beneficial to treat and predict the disease.Currently,the exact mo...BACKGROUND Hepatocellular carcinoma(HCC)has been a pervasive malignancy throughout the world with elevated mortality.Efficient therapeutic targets are beneficial to treat and predict the disease.Currently,the exact molecular mechanisms leading to the progression of HCC are still unclear.Research has shown that the microRNA-142-3p level decreases in HCC,whereas bioinformatics analysis of the cancer genome atlas database shows the ASH1L expression increased among liver tumor tissues.In this paper,we will explore the effects and mechanisms of microRNA-142-3p and ASH1L affect the prognosis of HCC patients and HCC cell bioactivity,and the association between them.AIM To investigate the effects and mechanisms of microRNA-142-3p and ASH1L on the HCC cell bioactivity and prognosis of HCC patients.METHODS In this study,we grouped HCC patients according to their immunohistochemistry results of ASH1L with pathological tissues,and retrospectively analyzed the prognosis of HCC patients.Furthermore,explored the roles and mechanisms of microRNA-142-3p and ASH1L by cellular and animal experiments,which involved the following experimental methods:Immunohistochemical staining,western blot,quantitative real-time-polymerase chain reaction,flow cytometric analysis,tumor xenografts in nude mice,etc.The statistical methods involved in this study contained t-test,one-way analysis of variance,theχ^(2)test,the Kaplan-Meier approach and the log-rank test.RESULTS In this study,we found that HCC patients with high expression of ASH1L possess a more recurrence rate as well as a decreased overall survival rate.ASH1L promotes the tumorigenicity of HCC and microRNA-142-3p exhibits reduced expression in HCC tissues and interacts with ASH1L through targeting the ASH1L 3′untranslated region.Furthermore,microRNA-142-3p promotes apoptosis and inhibits proliferation,invasion,and migration of HCC cell lines in vitro via ASH1L.For the exploration mechanism,we found ASH1L may promote an immunosuppressive microenvironment in HCC and ASH1L affects the expression of the cell junction protein zonula occludens-1,which is potentially relevant to the immune system.CONCLUSION Loss function of microRNA-142-3p induces cancer progression and immune evasion through upregulation of ASH1L in HCC.Both microRNA-142-3p and ASH1L can feature as new biomarker for HCC in the future.展开更多
Branchio-oto-renal(BOR)syndrome is an uncommon disorder inherited in an autosomal dominant manner.Its main clinical manifestations include branchial cleft cysts,anterior auricular fistula,hearing impairment,and kidney...Branchio-oto-renal(BOR)syndrome is an uncommon disorder inherited in an autosomal dominant manner.Its main clinical manifestations include branchial cleft cysts,anterior auricular fistula,hearing impairment,and kidney malformations.BOR syndrome is associated with heterozygous pathogenic variants including EYA1,SIX1,and SIX5.The study focused on a 13-year-old Chinese boy who presented with hearing impairment,renal malformations,and bony atresia of the right external auditory canal with microtia.The boy's clinical manifestations met the diagnostic criteria for BOR syndrome.Two of the boy's family members underwent clinical examination.However,neither displayed a phenotype associated with BOR syndrome.The boy and his two relatives provided blood samples for genomic DNA extraction,followed by Sanger sequencing.A novel mutation in the GREB1L gene was identified in the boy,but neither of his family members exhibited the same variant.Identifying a novel mutation in GREB1L offers valuable insights into the genotype-phenotype correlation of BOR syndrome,improving the precision of early diagnosis and promoting the advancement of personalized treatment strategies.展开更多
Estrus represents a critical phase in the porcine reproductive cycle and relies on functional ovarian development and coordinated steroidogenesis.Granulosa cells(GCs)mediate these processes by secreting estradiol(E_(2...Estrus represents a critical phase in the porcine reproductive cycle and relies on functional ovarian development and coordinated steroidogenesis.Granulosa cells(GCs)mediate these processes by secreting estradiol(E_(2))and progesterone(P_(4)),which are essential for follicular maturation and ovulatory competence.While circular RNAs(circRNAs)have been implicated in steroid hormone synthesis,their involvement in the regulation of gilt estrous remains unclear.In this study,circRNA sequencing was performed on ovarian tissues of estrus(ES)and non-estrus(NES)gilts,resulting in the identification of a novel circRNA,termed circular SHOC2 leucine rich repeat scaffold protein(circSHOC2),which exhibited marked up-regulation in ES ovaries.Functional assays demonstrated that circSHOC2 overexpression enhanced E_(2)and P_(4)synthesis and increased the protein levels of key steroidogenic enzymes.Mechanistic investigation revealed that circSHOC2 sponges miR-130b-5p.Silencing miR-130b-5p significantly enhanced E_(2)and P_(4)production,along with the up-regulation of steroidogenic proteins.Additionally,miR-130b-5p targeted ASH1-like histone lysine methyltransferase(ASH1L),while its overexpression significantly inhibited ASH1L.Cotransfection experiments revealed that ASH1L mitigated the inhibitory effects of miR-130b-5p on E_(2)and P_(4)synthesis in GCs.These findings establish a regulatory axis in which circSHOC2 modulates steroidogenic capacity in porcine GCs via the miR-130b-5p/ASH1L pathway,offering mechanistic insight into the molecular basis of gilt estrus and providing potential targets to enhance reproductive efficiency.展开更多
基金funded by Shanghai Science and Technology Innovation Action Plan Project(22140901100)Shanghai Key Laboratory of Molecular Imaging(18DZ2260400)Shanghai University of Medicine and Health Science Seed Fund(SSF-24-21-01).
文摘Background:Hepatocellular carcinoma(HCC)is a highly lethal malignancy driven by both intrinsic oncogenic pathways and immune microenvironmental regulation.Emerging evidence suggests that DNASE1L3 may influence tumor biology and immune responses;however,its specific roles in HCC progression and macrophage-mediated regulation remain unclear.This study aimed to elucidate the biological functions of DNASE1L3 in HCC and to determine how it modulates tumor behavior and immune interactions.Methods:Bioinformatics analyses of the GSE41804 and Cancer Genome Atlas-Liver Hepatocellular Carcinoma(TCGA-LIHC)datasets were used to identify hub genes.Functional assays assessed the impact of DNASE1L3 on HCC cell proliferation,migration,invasion,and cell cycle progression.The effects of DNASE1L3 on macrophage polarization and the Wnt/β-catenin signaling pathway were examined using a co-culture system.An HCC organoid model was established to further validate its regulatory function.Results:Eight prognostic signature genes were identified,with deoxyribonuclease I-like 3(DNase I-like 3)selected as the hub gene.DNASE1L3 overexpression suppressed HCC cell growth,inhibited migration and invasion,induced G1 arrest,and modulated epithelial-mesenchymal transition(EMT)markers.DNASE1L3 knockdown promoted M2-like macrophage polarization.Mechanistically,DNASE1L3 interacted withβ-catenin to enhance its ubiquitination and degradation,thereby inhibiting Wnt/β-catenin signaling and reducing PD-L1 expression.DNASE1L3 overexpression similarly restricted organoid growth and suppressed pathway activity.Conclusion:DNASE1L3 acts as a negative regulator of HCC progression by targeting the Wnt/β-catenin pathway and reducing PD-L1 expression,thereby influencing both tumor cell behavior and macrophage-mediated immune responses.
基金Supported by the Haihe Laboratory of Cell Ecosystem Innovation Fund,No.22HHXBJC00001the Key Discipline Special Project of Tianjin Municipal Health Commission,No.TJWJ2022XK016.
文摘BACKGROUND Hepatocellular carcinoma(HCC)has been a pervasive malignancy throughout the world with elevated mortality.Efficient therapeutic targets are beneficial to treat and predict the disease.Currently,the exact molecular mechanisms leading to the progression of HCC are still unclear.Research has shown that the microRNA-142-3p level decreases in HCC,whereas bioinformatics analysis of the cancer genome atlas database shows the ASH1L expression increased among liver tumor tissues.In this paper,we will explore the effects and mechanisms of microRNA-142-3p and ASH1L affect the prognosis of HCC patients and HCC cell bioactivity,and the association between them.AIM To investigate the effects and mechanisms of microRNA-142-3p and ASH1L on the HCC cell bioactivity and prognosis of HCC patients.METHODS In this study,we grouped HCC patients according to their immunohistochemistry results of ASH1L with pathological tissues,and retrospectively analyzed the prognosis of HCC patients.Furthermore,explored the roles and mechanisms of microRNA-142-3p and ASH1L by cellular and animal experiments,which involved the following experimental methods:Immunohistochemical staining,western blot,quantitative real-time-polymerase chain reaction,flow cytometric analysis,tumor xenografts in nude mice,etc.The statistical methods involved in this study contained t-test,one-way analysis of variance,theχ^(2)test,the Kaplan-Meier approach and the log-rank test.RESULTS In this study,we found that HCC patients with high expression of ASH1L possess a more recurrence rate as well as a decreased overall survival rate.ASH1L promotes the tumorigenicity of HCC and microRNA-142-3p exhibits reduced expression in HCC tissues and interacts with ASH1L through targeting the ASH1L 3′untranslated region.Furthermore,microRNA-142-3p promotes apoptosis and inhibits proliferation,invasion,and migration of HCC cell lines in vitro via ASH1L.For the exploration mechanism,we found ASH1L may promote an immunosuppressive microenvironment in HCC and ASH1L affects the expression of the cell junction protein zonula occludens-1,which is potentially relevant to the immune system.CONCLUSION Loss function of microRNA-142-3p induces cancer progression and immune evasion through upregulation of ASH1L in HCC.Both microRNA-142-3p and ASH1L can feature as new biomarker for HCC in the future.
文摘Branchio-oto-renal(BOR)syndrome is an uncommon disorder inherited in an autosomal dominant manner.Its main clinical manifestations include branchial cleft cysts,anterior auricular fistula,hearing impairment,and kidney malformations.BOR syndrome is associated with heterozygous pathogenic variants including EYA1,SIX1,and SIX5.The study focused on a 13-year-old Chinese boy who presented with hearing impairment,renal malformations,and bony atresia of the right external auditory canal with microtia.The boy's clinical manifestations met the diagnostic criteria for BOR syndrome.Two of the boy's family members underwent clinical examination.However,neither displayed a phenotype associated with BOR syndrome.The boy and his two relatives provided blood samples for genomic DNA extraction,followed by Sanger sequencing.A novel mutation in the GREB1L gene was identified in the boy,but neither of his family members exhibited the same variant.Identifying a novel mutation in GREB1L offers valuable insights into the genotype-phenotype correlation of BOR syndrome,improving the precision of early diagnosis and promoting the advancement of personalized treatment strategies.
基金supported by the National Key Research and Development Program of China(2022YFD1300303,2021YFF1000602)National Natural Science Foundation of China(32472878)China Agriculture Research System(CARS-35-PIG)。
文摘Estrus represents a critical phase in the porcine reproductive cycle and relies on functional ovarian development and coordinated steroidogenesis.Granulosa cells(GCs)mediate these processes by secreting estradiol(E_(2))and progesterone(P_(4)),which are essential for follicular maturation and ovulatory competence.While circular RNAs(circRNAs)have been implicated in steroid hormone synthesis,their involvement in the regulation of gilt estrous remains unclear.In this study,circRNA sequencing was performed on ovarian tissues of estrus(ES)and non-estrus(NES)gilts,resulting in the identification of a novel circRNA,termed circular SHOC2 leucine rich repeat scaffold protein(circSHOC2),which exhibited marked up-regulation in ES ovaries.Functional assays demonstrated that circSHOC2 overexpression enhanced E_(2)and P_(4)synthesis and increased the protein levels of key steroidogenic enzymes.Mechanistic investigation revealed that circSHOC2 sponges miR-130b-5p.Silencing miR-130b-5p significantly enhanced E_(2)and P_(4)production,along with the up-regulation of steroidogenic proteins.Additionally,miR-130b-5p targeted ASH1-like histone lysine methyltransferase(ASH1L),while its overexpression significantly inhibited ASH1L.Cotransfection experiments revealed that ASH1L mitigated the inhibitory effects of miR-130b-5p on E_(2)and P_(4)synthesis in GCs.These findings establish a regulatory axis in which circSHOC2 modulates steroidogenic capacity in porcine GCs via the miR-130b-5p/ASH1L pathway,offering mechanistic insight into the molecular basis of gilt estrus and providing potential targets to enhance reproductive efficiency.
